Q32 Bio Ownership | Who Owns Q32 Bio?


OverviewForecastFinancialsChart

Q32 Bio Ownership Summary


Q32 Bio is owned by 4.73% institutional investors, 6.45% insiders, and 88.82% retail investors. Orbimed advisors is the largest institutional shareholder, holding 18.47% of QTTB shares.

QTTB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockQ32 Bio4.73%6.45%88.82%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors2.25M18.47%$4.46M
Atlas venture life science advisors2.09M17.15%$4.14M
Carlyle group1.10M9.04%$2.13M
Acorn capital advisors803.42K6.59%$1.59M
Arch venture management320.48K2.63%$634.55K
Vanguard group321.05K2.62%$1.07M
Pfizer277.78K2.27%$922.22K
Sanofi244.08K1.99%$810.36K
Geode capital management106.11K0.87%$352.39K
Renaissance99.60K0.81%$330.67K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Acorn capital advisors803.42K0.81%$1.59M
Atlas venture life science advisors2.09M0.55%$4.14M
Pfizer277.78K0.39%$922.22K
Sanofi244.08K0.26%$810.36K
Arch venture management320.48K0.13%$634.55K
Orbimed advisors2.25M0.11%$4.46M
Carlyle group1.10M0.05%$2.13M
Monaco asset management sam50.92K0.03%$169.05K
Affinity asset advisors27.78K0.00%$55.00K
Two sigma securities13.75K0.00%$27.22K

Top Buyers

HolderShares% AssetsChange
Renaissance99.60K0.00%52.30K
Two sigma investments, lp31.51K0.00%31.51K
Vanguard group321.05K-25.64K
Jane street group25.37K-25.37K
Acadian asset management48.37K0.00%18.63K

Top Sellers

HolderShares% AssetsChange
Sio capital management---697.41K
Temasek (private)---313.94K
Monaco asset management sam50.92K0.03%-260.22K
Trustees of columbia university in the city of new york---133.90K
Arrowmark colorado---81.48K

New Positions

HolderShares% AssetsChangeValue
Two sigma investments, lp31.51K0.00%31.51K$62.38K
Two sigma securities13.75K0.00%13.75K$27.22K
Rockefeller capital management577.00-577.00$1.14K
Northwestern mutual wealth management30.00-30.00$100.00

Sold Out

HolderChange
National bank of canada /fi/-1.00
Thompson investment management-4.00
Cbiz investment advisory services-5.00
Farther finance advisors-6.00
Bfsg-11.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20258-84.62%579,164-93.13%40.10%2-88.24%2-88.89%
Sep 30, 202517-71.19%1,987,514-77.86%160.30%5-77.27%7-63.16%
Jun 30, 202558-15.94%8,975,90322.91%732.05%22-12.00%19-5.00%
Mar 31, 202570-25.53%9,406,755-13.54%770.95%26-57.38%20122.22%
Dec 31, 20249533.80%10,995,64120.72%911.60%6240.91%912.50%

Recent Insider Transactions


DateNameRoleActivityValue
Feb 25, 2026Kalowski Lee CFO and PresidentSell$18.04K
Feb 25, 2026Morrison Jodie Pope CEOSell$44.67K
Feb 25, 2026Violette Shelia M. Chief Scientific OfficerSell$12.71K
Dec 02, 2025Morrison Jodie Pope CEOSell$77.87K
Dec 02, 2025Kalowski Lee CFO and PresidentSell$31.40K

Insider Transactions Trends


DateBuySell
2026 Q1-3
2025 Q4-2
2025 Q3-3
2025 Q1--
2024 Q4--

QTTB Ownership FAQ


Who Owns Q32 Bio?

Q32 Bio shareholders are primarily institutional investors at 4.73%, followed by 6.45% insiders and 88.82% retail investors. The average institutional ownership in Q32 Bio's industry, Biotech Stocks , is 381.47%, which Q32 Bio falls below.

Who owns the most shares of Q32 Bio?

Q32 Bio’s largest shareholders are Orbimed advisors (2.25M shares, 18.47%), Atlas venture life science advisors (2.09M shares, 17.15%), and Carlyle group (1.1M shares, 9.04%). Together, they hold 44.66% of Q32 Bio’s total shares outstanding.

Does Blackrock own Q32 Bio?

BlackRock is not among the top 10 institutional shareholders of Q32 Bio.

Who is Q32 Bio’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is Q32 Bio’s biggest shareholder by percentage of total assets invested, with 0.81% of its assets in 803.42K Q32 Bio shares, valued at 1.59M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools